Table 4.
Comparison of ACL dimensions at two months after surgery at harvest between aseptic, ETO, and EBEAM treatment groups. n = 2. No comparisons are considered significant or substantial with P-values >0.2 and d-values <0.34.
| Surgical Group |
ACL Length |
95% CI |
ACL Width |
95% CI |
ACL Depth |
95% CI |
ACL Volume |
95% CI |
|---|---|---|---|---|---|---|---|---|
| ASEPTIC | 34.0 | 69.6 −1.6 |
5.5 | 7.3 3.7 |
11.1 | 58.1 −35.9 |
2515 | 22453 −17451 |
| ETO | 29.3 | 38.8 19.7 |
5.8 | 27.4 −15.7 |
12.7 | 30.5 −5.1 |
2209 | 10899 −6480 |
| EBEAM | 32.6 | 54.8 10.3 |
5.9 | 23.0 −11.3 |
10.6 | 24.4 −7.3 |
2017 | 3479 554 |
| P-value | >0.2 | >0.55 | 1.0 | 1 | ||||
| d-value | <0.34 | <0.04 | <0.28 | <0.05 | ||||
95% CI – 95% confidence interval
ACL – Anterior cruciate ligament